January
The CDC updated the International Classification of Diseases codes
for HIV infection for use with U.S. morbidity and mortality data. |
January
The CDC published guidelines developed for educational efforts to
combat AIDS. |
February
On February 12, trimetrexate was the first AIDS drug granted pre-approval
distribution status under new FDA regulations. The drug was used to
treat Pneumocystis carinii pneumonia in AIDS patients who could not
tolerate standard treatments. |
March
A total of 136 countries or territories reported a total of 84,256
cases of AIDS to the WHO Global Programme on AIDS. |
April
The NIH reported that between 1981 and 1988, two workers in laboratories
producing large quantities of HIV had been infected with HIV, and
it issued biosafety recommendations for laboratories. |
April
NIAID established an AIDS reagent repository to catalogue and expedite
the availability of experimental materials used in AIDS research. |
June
The CDC reported that a new AIDS case was reported every 14 minutes. |
June
The brochure “Understanding AIDS,” prepared by Surgeon
General C. Everett Koop in collaboration with the CDC, was mailed
to every household in the United States. |
June
NIAID and NICHD established an epidemiologic study of HIV transmission
during pregnancy and birth, the Women and Infants Transmission Study
(WITS). |
August
The CDC reported 72,024 cases of AIDS in the United States and estimated
that 1 to 1.5 million Americans were infected with HIV. |
August
NIAID’s AIDS Vaccine Evaluation Units initiated their first
study of an experimental AIDS vaccine. |
September
The World Health Organization reported that 111,000 cases of AIDS
had been documented worldwide. Authorities at WHO placed the actual
number of cases, including those unreported, at 250,000. |
September
NIDR investigators reported that saliva inhibits transmission of HIV. |
October
AIDS protestors, demanding a quicker approval process for drug treatments,
shut down the FDA. |
October
On October 13, NIAID established three programs: the Centers for AIDS
Research (CFARS) to improve the diagnosis, treatment, and prevention
of AIDS; the Pediatric AIDS Clinical Trials Units (Pediatric ACTUs),
a network of clinical sites to test experimental HIV drugs in children;
and the Programs for Excellence in Basic Research (PEBRA), to develop
novel strategies to determine how HIV causes disease. |
November
NIAID established the International Collaborations in AIDS Research
(ICAR) program to encourage studies of AIDS in Africa, Mexico, and
Brazil. |
November
NIAID established the Clinical Programs for Clinical Research on AIDS
(CPCRA) to involve community physicians in AIDS research. |
November
A CDC study revealed that 3 of every 1,000 college students are infected
with HIV. |
November
The NIH Office of AIDS Research (OAR) was established. |
November
On November 21, FDA licensed Intron A and Roferon A (human alpha interferon
injection) for the treatment of Kaposi’s sarcoma. |
November
On November 28, FDA authorized pre-approval distribution of ganciclovir
under a treatment IND protocol for the treatment of cytomegalovirus
retinitis in AIDS patients. |
December
NIAID funds a natural history study, HATS, in male and female heterosexuals
at high risk of AIDS who are not IV drug users. The study is modeled
on the MACS. |
December
On December 1, WHO’s Global Programme on AIDS instituted the
first World AIDS Day as an annual event. |
December
On December 22, Dr. Samuel Broder was named NCI director. |
| |
